|
|
| | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) Basic information |
| Product Name: | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | | Synonyms: | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) Structure]() |
| | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) Chemical Properties |
| | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) Usage And Synthesis |
| Description | Caveolin-1 (82-101) amide is a 20-amino acid synthetic peptide fragment corresponding to residues 82-101 of caveolin-1, which is involved in endocytosis and interacts with a variety of receptors and other proteins.1 Caveolin-1 (82-101) (0.8 µmol/kg) reduces aging-induced increases in microvascular leakage and fibrosis, as well as the ratio of phosphorylated-to-unphosphorylated PDGFR and protein-rich tyrosine 2 (Pyk2), in aged mouse heart, kidney, and brain. It also increases left ventricular ejection fraction and fractional shortening and reduces aging-induced isovolumic relaxation time (IVRT) and cardiac hypertrophy in aged mice.WARNING This product is not for human or veterinary use. | | References | [1] DHANDAPANI KUPPUSWAMY. The Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple Organs.[J]. Journal of Pharmacology and Experimental Therapeutics, 2021, 378 1: 1-9. DOI: 10.1124/jpet.120.000424 |
| | Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) Preparation Products And Raw materials |
|